Organon holds special shareholder meeting on merger agreement proposal

Organon held a special shareholder meeting on July 23, 2026, to vote on its proposed merger with Sun Pharmaceutical Holdings USA. Shareholders approved the merger agreement, allowing the transaction to proceed pending completion, and also backed a non-binding advisory resolution regarding merger-related executive compensation.

Organon held a special shareholder meeting on July 23, 2026 to vote on a merger agreement with Sun Pharmaceutical Holdings USA. * Shareholders adopted the merger agreement, authorizing the transaction to proceed subject to completion of the merger. * Investors also backed a non-binding advisory resolution on merger-related executive compensation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-314587), on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Organon held a special shareholder meeting on July 23, 2026 to vote on a merger agreement with Sun Pharmaceutical Holdings USA. * Shareholders adopted the merger agreement, authorizing the transaction to proceed subject to completion of the merger. * Investors also backed a non-binding advisory resolution on merger-related executive compensation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-314587), on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here